An Effective Treatment for Heart Failure Caused by Valvular Heart Diseases: Thoracic Sympathetic Block
- 27 February 2017
- journal article
- research article
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 31 (3) , 236-240
Abstract
Background: The pilot study is designed to investigate the effect of continuous thoracic sympathetic block (TSB) on cardiac function, reconstruction, and hemodynamic parameters in patients with heart failure resulting from valvular heart disease. Method: The cardiac function parameters, including left ventricle ejection fraction (LVEF), left ventricle end-diastole diameter (LVEDD), fractional shortening (FS), and N-terminal prohormone of brain natriuretic peptide (NT-proBNP), were measured in 19 patients before and after TSB treatment. The patients were also classified on the basis of NYHA classification system. Results: 4 weeks of TSB administration improved cardiac function in 18 of 19 patients (94.74%). The patients' LVEF, LVEDD, and NT-proBNP were all improved significantly after treatment. Conclusions: The favorable clinical outcome of TSB administration suggests an alternative treatment for the patients with heart failure caused by valvular dysfunctions.Keywords
This publication has 15 references indexed in Scilit:
- The Effects of High Thoracic Epidural Anesthesia on Sympathetic Activity and Apoptosis in Experimentally Induced Congestive Heart FailureJournal of Cardiothoracic and Vascular Anesthesia, 2014
- Effects of thoracic epidural analgesia on plasma cAMP and cGMP levels in patients with heart failureJournal of Cardiothoracic Surgery, 2013
- Beta-Blockers and Outcome in Heart Failure and Atrial FibrillationJACC: Heart Failure, 2013
- Heart Rate Achieved or Beta-Blocker dose in Patients with Chronic Heart Failure: Which is the Better Target?European Journal of Heart Failure, 2012
- Risks and benefits of thoracic epidural anaesthesiaBritish Journal of Anaesthesia, 2011
- Usefulness of N-Terminal-Pro-B-Type Natriuretic Peptide as a Screening Tool for Identifying Pediatric Patients With Congenital Heart DiseaseLaboratory Medicine, 2011
- Valvular Heart Disease: Diagnosis and ManagementMayo Clinic Proceedings, 2010
- Sympathetic Nervous System Overactivity and Its Role in the Development of Cardiovascular DiseasePhysiological Reviews, 2010
- The Sympathetic Nervous System in Heart FailureJACC, 2009
- Use of a high thoracic epidural analgesia for treatment of end-stage congestive heart failure secondary to coronary artery diseaseInternational Journal of Cardiology, 2008